2022 Achieving ISO 17025 TAF accreditation
2021 MOU signed with NTU Hsin-Chu Biomedical Park Branch
2021 Phalanx Biotech acquired Guzip Biomarkers Corporation
2021 EU declaration of conformity (DoC) & CE (Declaration of Conformity) certified
2021 MPap® BHLHE22/CDO1 certified with IVD ClassIII
2021 Office relocation to Hsinchu Biomedical Science Park
2021 Achieving ISO 13485 certification
2020 CAP Survey certified
2020 Endometrial Cancer - MPap® test on the market
2019 Liver Cancer – LiverEDx test on the market
2019The genetic lab received ISO 17025 TAF certification
2019Received Taiwan GMP certification for medical device manufacturer
2019Launching of SNP genetic risk detection platform for Alzheimer’s Disease risks
2018Launching of reproductive medicine gene test products
2017Launching of SNP genetic risk detection platform for obesity predisposition
2017Launching of NGS MedExome
2017The second BioPhalanx biotechnology development forum: Different professions, common goal
2016Signed Department of Nutrition, China Medical University for the development of individualized nutritional genomics
2016Launched SNP gene risk detection platform to include the risk detection for numerous cancers and chronic diseases
2016Developed high-throughput gene detection services by means of industry-academic alliance with National Central University
2016Signed MOU with Thai company MYGENES
2016The genetic laboratory received ISO 17025 certification and provides the genetic test compliant to international standards
2016The first BioPhalanx biotechnology development forum
2015Signed MOU with Malaysian company Gnosis to promote the developmental delay detection platform
2015Launching of revised “Human miRNA OneArray® v7”
2015Launched the NGS MedExome project
2015Started the NGS service
2015Signed MOU with Xiangua Laboratory and Biomiao Biotech for collaboration in the development of tests for development delay
2014Launching of mice and rat miRNA microarray (MRmiOA v6)
2014Published a total of 361 articles
2013Taiwan Biomedical and Bioagricultural Industry Biomedical Quality Award
2013Signed MOU with Shanghai Children’s Hospital
2013Launching of new MOA v2.1 microarray
2013Launching of “mice and rat miRNA microarray v5”
2013Received 2013 Excellence in Biotechnology Industry Award: Innovation of the Year
2012 OneArray Biotech, Phalanx’s subsidiary, was established in Kunshan, China
2012Launching of chromosomal microarray CytoOneArray®
2012ISO certification and one of Discovery’s five top biotechnology companies of the world
2012Launching of new independently developed “Human miRNA OneArray®”
2011Launching of miRNA OneArray® v3 of model plants, including seven common plants
2011Started to provide testing for microarrays carrying trace RNA/degraded RNA (OneArray®/miRNA microarray)
2011Launching of “miRNA OneArray® v3” of human and mice and rat versions
2010Launching of “human miRNA microarray v2” and “mice and rat miRNA microarray v2”
2010Received 2010 Taipei Biotechnology Award “Technology Commercialization Copper Award”
2010Received “Excellence in SBIR Innovative Service Award” and Taipei Biotechnology Award “Technology Commercialization Copper Award” Launching of “Yeast OneArray® v1” Launching of “Human OneArray® v5”
2010Received the 2010 “Excellence in SBIR Innovative Service Award” from the Department of Industrial Technology, Ministry of Economic Affairs for “Chain Platform for Gene Expression Test Service Development Program”
2009Started Cyto array project
2009Phalanx Biotech started to provide miRNA detection service
2009Launching of “primate miRNA microarray v1”, “mice and rat miRNA v1,” “animal miRNA microarray v1” and “plant miRNA microarray v1”
2008Launching of mice microarrays
2007Launching of “Mice OneArray® v1”
2006Gene expression profiling test becomes available
2006Launching of “Human OneArray® v4.3”
2005Best Contribution Award, Industrial Technology Research Institute
2002Establishment of Phalanx Biotech